Sanofi’s Dupixent eczema injection is likely to get its EU approval very soon – and the company has shared new data reinforcing its potential in patients who don't responde
Cancer Research UK (CRUK) has said it will award £123 million ($150 million) in funding over the next seven years to Scotland’s Beatson Institute, which will be renamed th
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho